Browse the evidence

Fish with higher amounts of ω-3 fatty acids are associated with a lower risk of CVD.

Encouraging the consumption of oily fish rich in ω-3 fatty acids may be beneficial for patients at risk of CVD.

Type I and type II muscle fibres are activated when heavier and lighter loads are lifted to task failure.

Both heavy and light resistance training can be effective for muscle activation.

Substitution of low- and no-calorie sweetened beverages (LNCSBs) for sugar-sweetened beverages (SSBs) was associated with a reduction in body weight by 1.06 kg.

Practitioners may consider recommending LNCSBs as a substitute for SSBs to aid in weight management.

Substitution of LNCSBs for SSBs was associated with a reduction in body mass index (BMI) by 0.32.

Practitioners may use LNCSBs to help reduce BMI in at-risk populations.

Early, frequent, and multimodal physical therapies are recommended during critical care.

Implement early and varied physical therapy interventions for patients in critical care to mitigate muscle atrophy.

Participants with OSA and type 2 diabetes mellitus receiving intensive lifestyle intervention (ILI) for weight loss had reduced OSA severity at 10 years.

Practitioners should consider ILI as an effective long-term strategy for managing OSA severity in patients with type 2 diabetes.

OSA remission at 10 years was more common with ILI (34.4%) than DSE (22.2%).

ILI may be a more effective approach for achieving OSA remission in this population.

The mean percent change in muscle growth favored eccentric compared with concentric actions (10.0% vs. 6.8%).

Eccentric training may lead to greater muscle growth compared to concentric training.

Both eccentric and concentric actions are effective in increasing muscle hypertrophy.

Incorporating both types of muscle actions can enhance hypertrophy outcomes.

After 2 years, lifestyle interventions can facilitate weight loss that equates to ~5%.

Practitioners can expect approximately 5% weight loss from lifestyle interventions over two years.

A multifactorial maintenance program is imperative to mitigate weight regain.

Implementing a comprehensive maintenance program is crucial for long-term weight management.

Both short and long inter-set rest intervals may be useful for achieving gains in muscle hypertrophy.

Practitioners can consider both short and long rest intervals in resistance training programs for muscle hypertrophy.

Nutritionally inadequate dietary intake is a leading contributor to chronic cardiometabolic diseases.

Practitioners should focus on improving dietary intake to prevent chronic diseases.

Multimodal prehabilitation including high-intensity training for colorectal cancer patients is feasible, safe, and effective.

Practitioners can implement a multimodal prehabilitation program to enhance recovery in colorectal cancer patients.

Eighty-six percent of patients with prehabilitation recovered to their baseline functional capacity 4 weeks postoperatively, compared to 40% in the control group.

Prehabilitation significantly improves recovery rates in colorectal cancer patients post-surgery.

In adults with obesity, GLP-1 receptor agonists demonstrate 15% to 20% weight loss.

GLP-1 receptor agonists can be considered effective for weight management in obese adults.

Bariatric surgery results in a mean weight loss of −22.68 kg compared to GLP-1 receptor agonists.

Bariatric surgery may be more effective than GLP-1 receptor agonists for significant weight loss.

Among meta-analyses, 4/5 with critically low quality showed low-carbohydrate diet superiority for weight loss (0.7-4.0 kg).

Low-carbohydrate diets may lead to significant weight loss, but caution is needed due to the quality of the evidence.

Individualized lifestyle interventions reduced the mean difference in BMI by -0.63 kg/m2 compared to control groups.

Practitioners can consider individualized lifestyle interventions as a method for weight management in SMI patients.

The risk ratio for losing ≥5% of baseline weight was 1.51 compared to control groups.

Practitioners can expect a significant proportion of SMI patients to achieve clinically relevant weight loss with these interventions.

Tirzepatide treatment was associated with greater decreases in glycated hemoglobin and body weight compared to GLP-1 RA.

Practitioners can expect tirzepatide to be more effective in managing blood sugar and weight in patients with type 2 diabetes.

Soy protein supplementation produces similar gains in strength and lean body mass (LBM) in response to resistance exercise training (RET) as whey protein.

Practitioners can consider soy protein as an effective alternative to whey protein for muscle gain.

Supplementing RET with whey or soy protein resulted in significant increases in strength.

Both whey and soy protein can be used to enhance strength gains during resistance training.

Tirzepatide (15 mg once weekly) resulted in weight loss of up to 17.8% after 72 weeks of therapy.

Tirzepatide is an effective option for weight loss in adults without diabetes.